GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference

Globe Newswire 4-Mar-2019 8:00 AM

SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the Cowen and Company 39^th Annual Health Care Conference in Boston on Monday, March 11, 2019, at 4:50 p.m. Eastern Time.

The presentation will be webcast live from GBT's website at www.gbt.com in the Investors section. A replay of the webcast will be archived and available for replay for one month following the event.

About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing two therapies for the potential treatment of sickle cell disease, including its late-stage product candidate, voxelotor, as an oral, once-daily therapy. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:
Myesha Lacy (investors)
GBT
650-351-4730
investor@gbt.com

Stephanie Yao (media)
GBT
650-741-7730
media@gbt.com